Stock 2126 JW (CAYMAN) THERAPEUTICS CO. LTD
Add to a list
To use this feature you must be a member
Log inSign up

Revisions JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Delayed Hong Kong S.E.
Other stock markets
 03:24:07 29/04/2024 BST 		5-day change 1st Jan Change
1.78 HKD +4.71% Intraday chart for JW (Cayman) Therapeutics Co. Ltd +3.49% -21.24%
03-20 JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 MT
03-20 JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 2126 Stock
  4. Revisions JW (Cayman) Therapeutics Co. Ltd